1 / 30

Fingernails

Fingernails. Conjunctiva. Skin. CT ABDOMEN. MRI BRAIN. Infective Endocarditis. Duke Criteria. Definative: 2 major, 1 major and 3 minor, 5 minor Possible: 1 major and 1 minor OR 3 minor crieria met. Duke Criteria. Major: Positive Blood culture: Evidence of endocardial involvement.

taurus
Download Presentation

Fingernails

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Fingernails

  2. Conjunctiva

  3. Skin

  4. CT ABDOMEN

  5. MRI BRAIN

  6. Infective Endocarditis

  7. Duke Criteria • Definative: 2 major, 1 major and 3 minor, 5 minor • Possible: 1 major and 1 minor OR 3 minor crieria met

  8. Duke Criteria • Major: • Positive Blood culture: • Evidence of endocardial involvement

  9. Duke Criteria – Major • Positive Blood culture: • Typical microorganism for infective endocarditis from two separate blood cultures • Viridans Streptococci, streptococcus bovis, HACEK group, staph aureas, Community acquired enterococcus in absence of a primary focus OR • Persistently positive blood culture (3/4 cultures or 2 cultures >12 hours apart) • Single positive for coxiella bunetti, or phase I IgG titer of >1:800

  10. Duke Criteria – Major • Endocardial Involvement • Positive Echo: • Oscillating intracardiac mass on valve or supporting structures in the path of regurgitant jet or in implanted material in the absence of an alternative anatomic explanation • Abscess • New partial dehiscence of prosthetic valve • New Valvular Regurgitation • Increase or change in previous murmur not sufficient

  11. Duke Criteria – Minor • Predisposing condition • Abnormal valve (prior endocarditis, rheumatic valvular disease, Aortic Valvular disease, complex cyanotic lesions, prosthesis • Abnormal risk (IVDU, indwelling catheters, poor dentition, hemodialysis, DM • Fever ≥38.0 C • Vascular Phenomena: • Major arterial emboli, septic pulmonary infarctions, mycotic aneurism, intracranial hemorrhage, conjunctival hemorrhages, Janeway lesions

  12. Duke Criteria – Minor • Immunologic Phenomena: Glomerulonephritis, Osler;s nodes, Roth’s sports, rheumatoid factor • Microbiologic evidence: • Positive blood culture but not meeting major criteria • Usu: gnr’s • Serologic evidence of active infection with organism consistent with infective endocarditis

  13. IE - Acute vs. Subacute • Acute • More virulent pathogen • Rapid valvular damage • Rapid hematogenous seeding of extracardiac sites • Untreated leads to death in days to weeks • Typical exam findings of vascular phenomenon: Janeway lesions, emboli, mycotic aneurisms

  14. IE - Acute vs. Subacute • Acute Organisms • Staphylococcus Aureas (MRSA and MSSA) • Beta Hemolytic Streptococcus • Pneumococcus • Enterococcus, Coag negative Staph (less commonly)

  15. IE - Acute vs. Subacute • Subacute • Indolent course. • gradual valvular damage • Rarely has seeding of extracardiac sites • Generally has more signs of rhematologic activation: roth spots, RF+, osler’s nodes, GN

  16. IE - Acute vs. Subacute • Subacute Organisms • Viridan’s Streptococcus • Enterococci • Coagulase negative Staph • HACEK • haemophilus ssp., • actinobaciullus actinomycetemcomitans, • cadiobacterium hominis, • eikenella corrodens, • kingella ssp. • Strep Bovis with colon cancer.

  17. Age old Debate - TTE vs. TEE

  18. Cardiac Complications • CHF – 30-40% • Consequence of valvular disease • Perivalvular Abscess • Perivalvular fistula • Pericarditis • Varying degrees of heart block • Mitral: may interrupt the AV node, or bundle of his • Aortic: non-cardiac or right sinus: upper interventricular system.

  19. Extra-cardiac Findings • Musculoskeletal • Septic and reative arthritis, bone infarctions, back pain, • Skin • Subungual hemorrhages, janeway lesions, osler’s nodes, • Eyes: • Roth’s spots, conjunctivalpetichiae, • Neuro: • CVA in up to 40%, aseptic and purulent meningitis, intracranial hemorrhage, seizures, encephalopathy, microabscesses in brain and meninges, • Renal: • Immune complex deposition in GBM, embolic infarcts, abscesses • Embolic: • Any organ can be involved but most often are skin, kidneys, spleen, skeletal system, brain and meninges

  20. Treatment • Medical Management: • Difficult to eradicate bacteria from the valve. • Should use long course of IV bacteriocidal antibiotics and static antibiotics should be avoided. • Antibiotic management should be held for cultures to be drawn. • Either 4 over the course of an hour, or 2 and 2 12 hours apart. • Even with appropriate management some may continue to spike fevers and have + BC

  21. Treatment – Medical Mgmt. • Strep ssp.: • Pen sensitive: Penicillin G, ceftriaxone, vanc for 4 wks, OR penicilin/ceftr plus gent for 2 weeks • Pen resistant: Penicillin G plus gent for 4-6wks OR Vanc 4 weeks • Enterococcus: • Pen g plus gen for 4-6 weeks, OR Amp plus gent for 4-6 weeks, OR vank plus gent for 4-6 weeks • HACEK: • Ceftriaxone for 4 weeks OR Amp/Sulbactam 4 weeks

  22. Treatment – Medical Mgmt. • MRSA • Native valve • Vanc for 4-6 weeks • Prosthetic valve • Vanc plus gent plus rifampin for 6-8 weeks • MSSA • Native valve • Naf/oxacillin/cefazolin 4-6 wks plus gent for 4-5 days, OR vanc for 4-6 weeks • Prosthetic valve • Naf/oxacillin for 6-8 weeks plus gent for 2 weeks plus rifampin for 6-8 weeks

  23. Treatment – Surgical • When to consider surgical therapy • Emergent (same day): • aortic reguritation and preclosure of mitral valve • sinus of valsalva abscess rupture into right heart • rupture into pericardial sac

  24. Treatment – Surgical • Urgent (1-2 days): • Valve obstruction by vegitation • Unstable prosthesis • Ao regurgitation with NYHA 3-4 CHF • Septal perforation • Perivalvular infection • Lack of effective antibiotic therapy • Major embolus plus persisting large vegetation (evidence conflicting but concensus opinion)

  25. Treatment – Surgical • Elective (earlier usually preferred): • Progressive paravalvular prothetic regurgitation • Valve dysfuntion plus persistent infection after 7-10 days of Abx • Fungal endocarditis (specifically mold) • Prosthetic vave: • With staph • <2 moths after preplacement • Fungal • Antibiotic resistant

  26. Treatment – Surgical • Abx after surgery: • If native valve and uncomplicated with negative valve cultures: • 2 weeks of post operative antibiotics OR a total full duration of above regimen whichever is longer • If complicated by perivalvular abscess, partially treated prosthetic valve infection or cases with culture positive valves: • Full course of antibiotics after surgery

  27. Complication rate: • Mortality with staph aureas: 70% with medical management - decreases to 25% with surgical intervention • Splenic abscess 3-5% • Should be treated with drain placement • Mycotic aneurisms: 2-15%, 50% in cerebral vasculature • Some resolve with Abx so monitor with cerebral angiography recommended • Persistent enlarging or periferal aneurisms should be resected surgically if possible • Vegitations • 50% remain unchanged 3 months after cure is achieved, and 25% have slight improvement

  28. Prophylaxis: • Indications: • Prosthetic heart valves • Prior endocarditis • Unrepaired cyanotic congenital heart disease • Completely repaired congential heart disease <6 months after repair) • Incompletely repaired congenital heart diease with residual defects adjacent to prosthetic material • Valvulopathy developing after cardiac transplantation

  29. Prophylaxis: • Regimens: • Standard: amoxicillin 2.0 g PO 1 hour prior to procedure • If pen allergic: • clarithromycin or azithro 500 mg prior to procedure • Cefalexin 2.0 g PO prior to procedure • Clindamycin 600 mg prior to procedure

  30. Bibliography • Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. American Journal of Medicine. 96(3):200-9, 1994. • Jennifer S. Li, Daniel J. Sexton, Nathan Mick, Richard Nettles, Vance G. Fowler, Jr., Thomas Ryan, Thomas Bashore, G. Ralph Corey . Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis. Clinical Infectious Diseases, Vol. 30, No. 4 (Apr., 2000), pp. 633-638 • Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. (2008). Harrison's principles of internal medicine (17th ed.). Pp.789-798; New York: McGraw-Hill Medical Publishing Division • Fuster, O’rourke, Walsh, Poole-Wilson. (2008). Hurst’s The heart Manual of Cardiology (12th ed.). 1975-2004. New York: McGraw-Hill Medical Publishing Division

More Related